Bio-Techne TECH Balance Sheet Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $209.82M+21.4% | $172.88M+19.3% | $144.96M-10.6% | $162.19M+15.3% | $140.67M-20.8% | ||
| $214.56M+16.2% | $184.61M+0.4% | $183.9M-11.1% | $206.88M-12.8% | $237.14M+8.8% | ||
| $201.18M-2.1% | $205.45M+1.1% | $203.19M+7.3% | $189.45M-0.9% | $191.08M+1.4% | ||
| $688.05M+7.9% | $637.43M+4.6% | $609.51M+0.2% | $608.3M-3.0% | $627.24M-1.2% | ||
| $232.99M-0.6% | $234.38M-2.5% | $240.33M-2.2% | $245.72M-2.5% | $251.98M+0.9% | ||
| $977.8M-0.3% | $980.56M+0.2% | $978.91M-0.2% | $980.94M+1.3% | $968.61M+0.4% | ||
| $319.07M-4.8% | $334.99M-4.3% | $350.11M-4.2% | $365.6M-17.6% | $443.7M-3.8% | ||
| $2.55B+1.1% | $2.52B-0.1% | $2.53B-1.2% | $2.56B-3.3% | $2.64B-1.0% | ||
| $23.49M-10.6% | $26.27M-12.9% | $30.16M+19.1% | $25.31M-20.0% | $31.64M-4.5% | ||
| $38.43M+23.9% | $31.03M+1.9% | $30.45M-6.5% | $32.57M+0.9% | $32.27M+16.4% | ||
| $153.28M+9.2% | $140.43M-2.8% | $144.55M-17.8% | $175.85M+3.9% | $169.2M+4.9% | ||
| $200M-23.1% | $260M-13.3% | $300M-13.3% | $346M+4.8% | $330M+10.0% | ||
| $1.57M+0.4% | $1.56M+0.1% | $1.56M+0.5% | $1.55M-1.1% | $1.57M-0.7% | ||
| $1.15B+3.5% | $1.11B+2.2% | $1.08B+1.5% | $1.07B-10.9% | $1.2B-7.0% | ||
| $2.09B+3.7% | $2.01B— | —— | $1.92B-4.9% | $2.02B-2.9% | ||
| $2.55B+1.1% | $2.52B-0.1% | $2.53B-1.2% | $2.56B-3.3% | $2.64B-1.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Bio-Techne's total assets?
- Bio-Techne (TECH) holds $2.6B in total assets, down 3.5% year over year.
- How much debt does Bio-Techne have?
- Bio-Techne carries $290.3M in total debt against $2.1B of shareholders' equity, a debt-to-equity ratio of 0.14.
- How much cash does Bio-Techne have?
- Bio-Techne holds $209.8M in cash and equivalents.
- Can Bio-Techne cover its short-term obligations?
- Its current ratio is 4.49 — current assets exceed current liabilities.
- Where does Bio-Techne's balance sheet data come from?
- Every line is extracted from Bio-Techne's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
